Page last updated: 2024-09-03

ym 022 and tetragastrin

ym 022 has been researched along with tetragastrin in 1 studies

Compound Research Comparison

Studies
(ym 022)
Trials
(ym 022)
Recent Studies (post-2010)
(ym 022)
Studies
(tetragastrin)
Trials
(tetragastrin)
Recent Studies (post-2010) (tetragastrin)
65185447232

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brammer, N; Dunlop, J; Ennis, C; Evans, N1

Other Studies

1 other study(ies) available for ym 022 and tetragastrin

ArticleYear
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.
    Biochemical pharmacology, 1997, Jul-01, Volume: 54, Issue:1

    Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Humans; Phenylurea Compounds; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Signal Transduction; Tetragastrin; Transfection

1997
chemdatabank.com